JPMorgan
http://www.jpmorgan.comJPMorgan Chase & Co. (NYSE: JPM) is a leading global financial services firm with assets of $1.5 trillion and operations in more than 50 countries. The firm is a leader in investment banking, financial services for consumers, small business and commercial banking, financial transaction processing, asset management, and private equity.
-
Analyst Round-Up InterMune (ITMN): 6 Downgrades Following FDA's Request for More Trials
-
Unusual 11 Mid-Day Movers 5/5: PCBC, CSPI, AMMD, TX, ESE Higher; ITMN, MYGN, LNCE, CLMT Lower
-
Notable Analyst Rating Changes 05/05: S, CAb, ERTS, AMMD Upgraded; ITMN, MRK, NWSA, MYGN Downgraded
-
Intermune (ITMN) option prices expensive into FDA for request for additional data
-
Notable Analyst Rating Changes 04/13: CROX, COP, SIRI, EXPE Upgraded; PCLN, ST, KEY, MON Downgraded
-
JPMorgan Starts Pharmasset (VRUS), InterMune (ITMN) at Overweight
-
Notable Analyst Rating Changes 03/10: ITMN, RDN, EIX, IFSIA Upgraded; FACT, VALE, PSS, NLY, AVAV Downgraded
